Improving lung cancer screening access and effectiveness
Official title: Increasing Equity in Lung Cancer Screening
Run by Indiana University · NCT06360822 · Data updated 2026-11-12
This study is trying to improve lung cancer screening in the emergency department by talking to patients and staff to see how well the process works and how it can be made better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 80 Years |
| Sex | All |
| Enrollment | 144 (estimated) |
| Sponsor | Indiana University Academic / other |
| Locations | 1 site (Indianapolis, Indiana) |
| Status | Recruiting |
| Started | December 1, 2023 |
| Main results expected | June 1, 2027 |
| Study ends | March 1, 2028 |
| Registry record updated | September 10, 2026 |
| Trial ID | NCT06360822 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 50-80 who have a history of smoking and meet specific criteria for lung cancer screening.
✕Probably not a fit
Patients who do not speak English or Spanish, have severe psychiatric conditions, or are currently enrolled in hospice care may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to enhance the Emergency Department Lung Cancer Screening (ED-LCS) intervention by conducting qualitative interviews with key stakeholders to refine the approach. It will pilot test the intervention to evaluate its efficacy, acceptability, and feasibility among eligible patients. Additionally, the study will gather in-depth descriptions of stakeholders' experiences to inform future improvements to the screening process.
Why it matters
Potential benefit: If successful, this study could lead to more effective lung cancer screening, ultimately improving early detection and patient outcomes.
How similar studies have gone: Other studies have shown promise in improving lung cancer screening interventions, suggesting that this approach may build on existing successful strategies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Eligible for LCS (50-80 years old, smoked in past 15 years, and smoked at least 20 pack years) Exclusion Criteria: * • Non-English/Spanish speaking * Decompensated psychiatric illness (suicidal, homicidal, psychosis). Will confirm with attending physicians at time of enrollment * Intoxicated with alcohol or drugs * Cannot provide reliable follow up contact information (cell phone) * Presenting to the ED with a life-threatening condition * Have received chest CT scan in past 12 months * Already enrolled in LCS * Hospice enrolled
Where it's running
-
Eskenazi Health
Indianapolis, Indiana, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients
This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.
-
Olive oil before lung cancer surgery to see if it lowers chylothorax
This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.